Verzenio

Eli Lilly’s growth drivers, Verzenio and Jardiance, suffer clinical setbacks
Fierce Pharma
Tue, 04/30/24 - 11:20 am
Eli Lilly
Jardiance
Verzenio
clinical trials
Eli Lilly’s Verzenio fails prostate cancer test as possible Novartis showdown nears
Fierce Pharma
Wed, 02/7/24 - 11:26 am
Eli Lilly
Verzenio
prostate cancer
FDA widens Lilly's Verzenio breast cancer reach, removes test and menopausal status demands
Fierce Pharma
Mon, 03/6/23 - 11:50 am
Eli Lilly
Verzenio
breast cancer
Top 10 Pharma TV Ad Spenders in 2022 — Anti-Inflammatories and Diabetes Drugs Dominate
Xtalks
Sun, 01/29/23 - 01:31 pm
television ads
pharma marketing
DTC ads
AbbVie
Rinvoq
Dupixent
Sanofi
Regeneron
Skyrizi
Novo Nordisk
Ozempic
Jardiance
Eli Lilly
Boehringer Ingelheim
Rybelsus
Trulicity
Rexulti
Otsuka
Lundbeck
Tremfya
JNJ
Verzenio
As Lilly gears up for key 2022 launches, Trulicity, Taltz and more drive solid growth
Fierce Pharma
Tue, 10/26/21 - 11:54 pm
Eli Lilly
earnings
Trulicity
Taltz
Verzenio
Emgality
Eli Lilly's Verzenio snags first-in-class FDA approval for early breast cancer. But limited label poses a challenge
Fierce Pharma
Wed, 10/13/21 - 11:07 am
Eli Lilly
Verzenio
FDA
early breast cancer
breast cancer
Lilly warms up for Olympics with Team USA athletes in ads for Trulicity, Emgality and Verzenio
Fierce Pharma
Wed, 07/7/21 - 10:29 pm
Eli Lilly
pharma marketing
Olympics
Trulicity
Emgality
Verzenio
Look for Eli Lilly's Verzenio to hit $4.6B, thanks to early breast cancer win: analyst
Fierce Pharma
Tue, 03/2/21 - 12:12 pm
Eli Lilly
Verzenio
breast cancer
early breast cancer
Ibrance trial failure dashes Pfizer’s growth hopes for the drug
Pharmaforum
Sun, 10/11/20 - 10:23 pm
Pfizer
Ibrance
breast cancer
Eli Lily
Verzenio
ESMO: Lilly's Verzenio pressures Pfizer with practice-changing win in early breast cancer
Fierce Pharma
Sun, 09/20/20 - 07:54 pm
Ibrance
Pfizer
Eli Lilly
Verzenio
breast cancer
ESMO
Eli Lilly Shares Surge After Successful 'Verzenio' Breast Cancer Drug Trial
TheStreet.com
Tue, 06/16/20 - 10:52 am
Eli Lilly
Verzenio
breast cancer
clinical trials
Three Breast Cancer Drugs: FDA Warns of Rare but Serious Lung Inflammation
RAPS.org
Sun, 09/15/19 - 09:47 pm
breast cancer
FDA
Ibrance
Kisqali
Verzenio
Pfizer
Novartis
Eli Lilly
Lilly cancer push boosted by survival benefit to key drug
Biopharma Dive
Tue, 07/30/19 - 11:31 am
Eli Lilly
Verzenio
metastatic breast cancer
clinical trials
Lilly price break reverses NICE’s 'No' ruling on breast cancer drug Verzenio
Fierce Pharma
Fri, 01/18/19 - 12:09 am
Eli Lilly
NICE
Verzenio
breast cancer
NICE spurns Lilly’s breast cancer drug Verzenio in favor of rivals from Pfizer and Novartisspir
Fierce Pharma
Sat, 10/20/18 - 10:37 pm
Lilly
Verzenio
breast cancer
Pfizer
Ibrance
Novartis
Kisqali
NICE
Lilly’s breast cancer drug Verzenio approved in EU
Pharmaforum
Sat, 10/6/18 - 12:45 pm
Eli Lilly
Verzenio
Euorpe
breast cancer
Large and Small: Here’s What’s Moving Eli Lilly and Zosano
Yahoo/Market Exclusive
Tue, 02/27/18 - 09:48 am
Eli Lilly
Zosano
Verzenio
advanced breast cancer
M207
migraine
AstraZeneca's Faslodex Gets FDA Nod for Use With Verzenio
Yahoo/Zacks.com
Thu, 11/16/17 - 11:13 am
AstraZeneca
Faslodex
FDA
breast cancer
Verzenio
Eli Lilly
Latecomer Verzenio stands out from Ibrance, Kisqali in launch's early days: Lilly
Fierce Pharma
Mon, 10/30/17 - 10:00 am
Verzenio
Ibrance
Kisqali
drug launches
breast cancer. Eli Lilly
Pfizer
Novartis
Lilly's lung cancer drug fails main goal of key study
Yahoo/Reuters
Tue, 10/10/17 - 09:35 am
Eli Lilly
lung cancer
clinical trials
Verzenio
non-small cell lung cancer

Pages